AKT1 and colorectal carcinoma: In a nude mouse model of colorectal cells (CRC), oral administration of WA (5 mg/kg) inhibited the tumor growth of human colorectal carcinoma (HCT-116) cells overexpressing AKT and micro-vessel formation.